09 January 2018 | News
A patient-centric outlook is the hope for the healthcare industry. This also includes the delivery of specific education and support patients need to make these decisions and participate in their own care
SQN is a world recognised specialist clinical biometrics contract research organisation (CRO CRO).
Following several years of research and development, SQN makes patient centricity a reality with the launch of the electronic Patient Reported Outcomes (ePRO) and Clinical Outcome Assessment (eCOA) app.
In drug development, patient participation is crucial to the success of clinical trials.
The industry recognises the demand for better in-trial patient data and improved communication between clinicians and patients.
When the patient is at the centre of the trial, researchers see improved uptake and retention, leading to more dependable results.
SQN Health is fully customisable for each and every trial, providing pharmaceutical and biotechnology companies with a bespoke, accurate and engaging way of collecting trial data.
Patients are immediately more connected to their trial and this leads to enhanced protocol compliance and continued trial participation.
SQN Health is a key addition to SQN's Clinical Data Ecosystem, which brings together an entire trial or development program in one cloud-based portal.
This ecosystem connects patients, investigator sites, laboratories and all project and clinical professionals involved in patient care and trial management.
Clinical oversight and patient engagement will be greatly enhanced.
Clinicians will have real-time access to patients' clinical trial data allowing remote monitoring and intervention when necessary.
Advanced, real-time data analytics, incorporating state-of-the-art artificial intelligence (AI) reporting, is a game changer in the management of patients and their data.